Skip to main content

NATIXIS

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1274981 PARIS, I0

Position in TEVA

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$409,300
-$9,288 QoQ
Shares Held
13,589
+1.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

NATIXIS holds $42,325,153 across 10 Drug Manufacturers - Specialty & Generic names. TEVA ranks #7 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 TEVA
Teva Pharmaceutical Industries Ltd
This page
13,589 $409,300

All Filings in TEVA

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $409,300 13,589
2025-12-31 $418,588 13,412
2025-09-30 $789,214 39,070
2025-06-30 $255,321 15,234
2025-03-31 $284,652 18,520
2024-06-30 $44,427 2,734
2022-12-31 $60,784 6,665
2022-03-31 $88,378 9,412
2021-12-31 $814,953 101,742
2021-09-30 $1,138,011 116,839
2021-03-31 $1,285,475 111,393
2020-12-31 $988,102 102,394
2020-09-30 $1,039,582 115,381
2020-06-30 $5,073,671 411,490
2020-03-31 $1,938,270 215,843